Article Information
History
- September 28, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Leo YY Lee1,†,
- Jie Zhou2,
- Paulina Koszalka1,3,
- Rebecca Frise2,
- Rubaiyea Farrukee4,
- Keiko Baba5,
- Shahjahan Miah6,
- Takao Shishido5,
- Monica Galiano7,
- Takashi Hashimoto5,
- Shinya Omoto5,
- Takeki Uehara5,
- Edin Mifsud1,4,
- Neil Collinson8,
- Klaus Kuhlbusch9,
- Barry Clinch8,
- Steffen Wildum9,
- Wendy Barclay2 and
- Aeron C Hurt1,4,9,*
- 1WHO Collaborating Centre for Reference and Research on Influenza, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia
- 2Department of Infectious Disease, Imperial College London, London, United Kingdom
- 3Biomedicine Discovery Institute & Department of Microbiology, Monash University, Victoria, Australia
- 4Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Parkville, Australia
- 5Shionogi & Co., Ltd, Osaka, Japan
- 6Public Health England, London, United Kingdom
- 7Francis Crick Institute, London, United Kingdom
- 8Roche Products Ltd, Welwyn Garden City, UK
- 9F. Hoffmann-La Roche Ltd, Basel, Switzerland
- ↵*For correspondence: aeron.hurt{at}roche.com